Skip to evidence report

NEU.INH_VIP.develop_niche: Studies — page 13

How association tiers are defined — cell–trait and gene–trait

SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.

Cell–trait tiers

Cell–trait links
Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
Required for Specific or Relevant
The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
Specific (Tier 1)
Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
Relevant (Tier 2)
Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
Interpretation and report values
CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
Meta traits and individual traits
Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.

Gene–trait priorities (variant–tCRE–gene evidence)

Variant–tCRE–gene links
Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
Required genetic support
The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
Required cellular support
The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
High priority
Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
Medium priority
Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
Same-record evidence and aggregation
Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
Limits of interpretation
A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.

State · 122 full-atlas cells · all tissues.

Marker genes and cell annotation · Open this population in Cell Browser →

ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.

Rows 12,001–12,313 of 12,313; ranked by score descending. Equal values use name/identifier order.

Studies ranked for NEU.INH_VIP.develop_niche
#Trait / studyIndividual trait IDMean IC score
12001CPXM1/MDK ratioGCST903142212.81e-06
12002MMP3 levelsGCST904699202.81e-06
12003Total lipids in very large VLDLGCST905006072.79e-06
12004Modified Stumvoll Insulin Sensitivity Index (model adjusted for BMI)GCST0036582.77e-06
12005CEACAM6 levelsGCST904686972.75e-06
12006DNAJB1/PPME1 ratioGCST903145102.72e-06
12007White blood cell countGCST900023742.71e-06
12008Triglycerides in VLDLGCST905002952.69e-06
12009DKK1 levelsGCST904689972.68e-06
12010AXIN1/SRPK2 ratioGCST903134172.64e-06
12011Red blood cell erythrocyte distribution width (UKB data field 30070)GCST904680992.63e-06
12012HPGDS/ITGAV ratioGCST903150802.60e-06
12013CD164/CD99 ratioGCST903137402.59e-06
12014PDGFB/TNFSF13 ratioGCST903156322.54e-06
12015DCTN1 levelsGCST904689582.54e-06
12016IL1R1/IL1RN ratioGCST903151582.52e-06
12017DSC2 levelsGCST904690402.51e-06
12018Heart rate variability (corrected root mean square of successive differences)GCST902812642.48e-06
12019CHI3L1 levelsGCST904687432.47e-06
12020DKK1/SERPINE1 ratioGCST903144802.46e-06
12021CD300E/EFNA4 ratioGCST903137972.43e-06
12022ATXN2L levelsGCST904684022.43e-06
12023MPIG6B levelsGCST904699352.39e-06
12024DDR1/PVR ratioGCST903144422.39e-06
12025CXCL16 levelsGCST904689282.39e-06
12026CCL27 levelsGCST904685792.36e-06
12027CCL5/SELP ratioGCST903137052.36e-06
12028ERBB4/NELL1 ratioGCST903146912.35e-06
12029SDC4 levelsGCST904705592.34e-06
12030EDAR/YES1 ratioGCST903145942.25e-06
12031CD248 levelsGCST904686122.23e-06
12032CEP43/TIA1 ratioGCST903140212.22e-06
12033DPP4 levelsGCST904690332.22e-06
12034Diacylglycerol_36:3_[M+H-H2O]1+ levelsGCST900601892.22e-06
12035ENPP6 levelsGCST904691172.22e-06
12036Chronic diseases of tonsils and adenoidsFING000002832.21e-06
12037Basophil countGCST900022922.18e-06
12038Neutrophil percentage of white cellsGCST900023992.18e-06
12039Myasthenia gravisGCST900930612.17e-06
12040Free Cholesterol to Total Lipids in Very Large VLDL percentageGCST905005932.15e-06
12041PCDHB15 levelsGCST904701732.15e-06
12042HRC levelsGCST904694752.14e-06
12043PDGFA levelsGCST904701882.13e-06
12044GLOD4/HSPA1A ratioGCST903149372.10e-06
12045PLXNB2 levelsGCST902422992.09e-06
12046LGALS3BP levelsGCST904697602.08e-06
12047FAP levelsGCST904691892.04e-06
12048KLRK1 levelsGCST904697132.03e-06
12049ATP5IF1/LYN ratioGCST903133891.98e-06
12050Sphingomyelin_32:1_[M+H]1+ levelsGCST900602251.98e-06
12051Job involved shift work | Employment historyUKBB000003821.97e-06
12052Other joint disordersFING000010641.94e-06
12053Monocyte countGCST900023411.94e-06
12054BMP4 levelsGCST904684531.94e-06
12055CD93/TNFRSF4 ratioGCST903139221.92e-06
12056COLEC12/TAFA5 ratioGCST903141851.89e-06
12057GCNT1 levelsGCST904693191.86e-06
12058PTPRC levelsGCST904703801.85e-06
12059Alzheimer's disease or family history of Alzheimer's diseaseGCST0073201.84e-06
12060CPQ levelsGCST904688461.84e-06
12061Bone marrow fat fraction of lumbar vertebra 4GCST906523891.83e-06
12062T1 CAT volume L PlanumPolareGCST903840861.77e-06
12063ALB levelsUKBB000000191.77e-06
12064CD86 levelsGCST904686541.77e-06
12065CERT/MAX ratioGCST903140281.77e-06
12066CD99/RELT ratioGCST903139301.75e-06
12067ADAM9 levelsGCST904682211.73e-06
12068Late-onset myasthenia gravisGCST900934661.70e-06
12069ROBO1 levelsGCST904704891.66e-06
12070Neutrophill percentage (UKB data field 30200)GCST904680931.64e-06
12071MMP3 levelsGCST900120271.64e-06
12072Concentration of chylomicrons and extremely large VLDL particlesGCST905010151.63e-06
12073TNFSF12/TNFSF13 ratioGCST903159411.61e-06
12074ANGPT1 levelsGCST904683001.60e-06
12075SPARC levelsGCST904707181.59e-06
12076BCAM/PCDH17 ratioGCST903134751.58e-06
12077Leiomyoma of uterusFING000007191.58e-06
12078DAG1/DKK1 ratioGCST903143731.56e-06
12079ATP5IF1/FIS1 ratioGCST903133851.56e-06
12080VMO1 levelsGCST904710421.56e-06
12081PDCD1/TNFRSF4 ratioGCST903156091.55e-06
12082Platelet countGCST902786401.53e-06
12083Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T111ECGU0001111.52e-06
12084Triglycerides to Total Lipids in Very Large VLDL percentageGCST905006921.50e-06
12085EGF/MPIG6B ratioGCST903146111.48e-06
12086F11R/TMSB10 ratioGCST903147291.47e-06
12087IDP T1 FAST ROIs L cerebellum crus IIGCST900025721.45e-06
12088SORT1/ST6GAL1 ratioGCST903158691.45e-06
12089HYOU1 levelsGCST904694961.43e-06
12090Granulocyte percentage of myeloid white cellsGCST0046081.43e-06
12091ADGRE5 levelsGCST904682381.42e-06
12092Cholesteryl Esters to Total Lipids in Large VLDL percentageGCST904981621.40e-06
12093White blood cell countGCST900024071.39e-06
12094Omega-6 fatty acids to total fatty acids percentageGCST905021211.37e-06
12095HIP1R levelsGCST904694531.33e-06
12096Platelet crit | Blood countUKBB000006471.32e-06
12097Triacylglycerol_56:7_[M+NH4]1+ levelsGCST900605511.32e-06
12098rfMRI connectivity (ICA100 edge 387)GCST900052401.28e-06
12099CD302 levelsGCST904686241.26e-06
12100ALB levelsGCST902786161.25e-06
12101CD69/CEP43 ratioGCST903138671.21e-06
12102aparc-DKTatlas lh area parstriangularisGCST900032521.21e-06
12103Renal failureFING000012501.20e-06
12104CD33 levelsGCST904686251.20e-06
12105ALB levelsGCST904971081.19e-06
12106KLRF1 levelsGCST904697121.18e-06
12107CLEC1B/SORT1 ratioGCST903141041.16e-06
12108triglyceride (maximum, inv-norm transformed)GCST904764311.16e-06
12109SUSD1 levelsGCST904707861.14e-06
12110Tyrosine levelsGCST905001561.14e-06
12111CLEC7A levelsGCST904687781.13e-06
12112CCL11 levelsGCST904685641.12e-06
12113LYN levelsGCST904698261.09e-06
12114Polyp of the female genital tractFING000011901.07e-06
12115CNPY4 levelsGCST904688001.06e-06
12116Skin red/green componentGCST903202581.05e-06
12117Neutrophill percentage | Blood countUKBB000004981.05e-06
12118CFP levelsGCST904687311.04e-06
12119Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010501.04e-06
12120ICOSLG levelsGCST904695031.03e-06
12121CD74/TIMD4 ratioGCST903138961.02e-06
12122Neutrophil countGCST900023519.94e-07
12123GFRA2 levelsGCST904693299.80e-07
12124FAP/LRRN1 ratioGCST903147839.75e-07
12125SELL levelsGCST904705679.70e-07
12126Neutrophill count (UKB data field 30140)GCST904680929.46e-07
12127COLEC12/TNFRSF1A ratioGCST903141879.42e-07
12128White blood cell (leukocyte) count | Blood countUKBB000009139.29e-07
12129NECTIN4 levelsGCST904700219.06e-07
12130VEGFB levelsGCST904710359.03e-07
12131CD300C/CLEC14A ratioGCST903137869.01e-07
12132FCGR3B levelsGCST904692028.95e-07
12133ARSB levelsGCST904683698.91e-07
12134FABP2/RBP2 ratioGCST903147578.82e-07
12135AMIGO2 levelsGCST904682928.79e-07
12136ADGRE5/ITGB2 ratioGCST903131808.74e-07
12137Total Lipids in VLDLGCST905002368.70e-07
12138APP/NID1 ratioGCST903133268.65e-07
12139SHBG levelsGCST904706228.59e-07
12140SELP levelsGCST904705698.42e-07
12141ENPP5 levelsGCST904691168.41e-07
12142Neutrophil countGCST900023988.30e-07
12143LIFR levelsGCST904697698.20e-07
12144Sporadic miscarriageGCST0118888.06e-07
12145SERPINE1 levelsGCST904705967.99e-07
12146LAT2/MANF ratioGCST903152777.94e-07
12147SNAP23/ZBTB16 ratioGCST903158587.94e-07
12148CD4 levelsGCST904686367.91e-07
12149NCAN levelsGCST904700057.74e-07
12150FURIN/PLA2G15 ratioGCST903148877.64e-07
12151White blood cell countGCST0046107.33e-07
12152Osteoporosis, osteopenia and pathological fracture (PheCode 743)GCST904762586.63e-07
12153L1CAM levelsGCST904697236.53e-07
12154NECTIN4/TGFBR2 ratioGCST903155356.50e-07
12155PALM3 levelsGCST904701536.49e-07
12156NOTCH2 levelsGCST904700666.34e-07
12157LDLR levelsGCST904697506.33e-07
12158BA-exvivo lh area BA45GCST900032156.31e-07
12159Alzheimer's disease (MTAG)GCST904490606.24e-07
12160Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905010926.10e-07
12161DPP10 levelsGCST904690326.05e-07
12162ICAM3/SLAMF7 ratioGCST903151235.61e-07
12163Telomere length (principal component 1)GCST904351445.52e-07
12164COMP/MYOC ratioGCST903141915.51e-07
12165GHR levelsGCST904693425.44e-07
12166CRTAM/PDCD1 ratioGCST903142795.35e-07
12167Hemangioma of skin and subcutaneous tissue (PheCode 228.1)GCST904756335.20e-07
12168APP/DAG1 ratioGCST903133204.98e-07
12169LGALS9/SIGLEC1 ratioGCST903153234.96e-07
12170SIGLEC1 levelsGCST904706324.76e-07
12171aseg global volume EstimatedTotalIntraCranialGCST900025974.74e-07
12172TNF levelsGCST904709244.57e-07
12173TNFRSF6B levelsGCST904709144.54e-07
12174MAVS/PPP1R9B ratioGCST903153934.53e-07
12175Alzheimer's disease (MTAG)GCST904490534.53e-07
12176Tyrosine levels (UKB data field 23469)GCST902695664.43e-07
12177PTP4A3 levelsGCST904703754.35e-07
12178Ulcerative proctitisFING000013934.34e-07
12179ITGB1BP2/SKAP2 ratioGCST903152194.28e-07
12180KLK13 levelsGCST904696994.23e-07
12181BCAM/CLEC14A ratioGCST903134704.19e-07
12182HBEGF levelsGCST904694334.19e-07
12183JAM2/TNFRSF21 ratioGCST903152424.13e-07
12184LUZP2 levelsGCST904698194.08e-07
12185APP levelsGCST904683444.07e-07
12186SEZ6L2 levelsGCST904706064.00e-07
12187ERBB3 levelsGCST904691403.96e-07
12188MANSC4 levelsGCST904698483.82e-07
12189VAMP8 levelsGCST904710253.79e-07
12190Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009293.55e-07
12191FCN2 levelsGCST904692043.44e-07
12192MCTS1 levelsGCST904698743.43e-07
12193CD163/IL18BP ratioGCST903137363.34e-07
12194ACVRL1/EFNA4 ratioGCST903131563.30e-07
12195TNFSF12 levelsGCST904709193.26e-07
12196Omega-6 fatty acids levelsGCST904991773.23e-07
12197ACP5 levelsGCST904682033.19e-07
12198FAM3B/FUT3_FUT5 ratioGCST903147773.18e-07
12199FCRLB levelsGCST904692103.03e-07
12200FABP4/FGF21 ratioGCST903147583.03e-07
12201IL1RN/LGALS9 ratioGCST903151602.93e-07
12202Deviated nasal septumFING000004092.88e-07
12203Other bacterial intestinal infectionsFING000009692.80e-07
12204CD59/CST6 ratioGCST903138572.67e-07
12205Epstein-Barr virus ZEBRA antibody levelsGCST900069012.58e-07
12206SRPK2/VASH1 ratioGCST903158862.56e-07
12207CCL5/RARRES2 ratioGCST903137042.55e-07
12208Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentageGCST905009562.55e-07
12209ADA2 levelsGCST904682152.48e-07
12210NBL1/NECTIN4 ratioGCST903155142.48e-07
12211FSTL3/LTBR ratioGCST903148832.46e-07
12212Forced expiratory volume in 1-second (FEV1), predicted percentage | SpirometryUKBB000002532.40e-07
12213CDH3/NECTIN4 ratioGCST903139522.30e-07
12214CD74/JAM2 ratioGCST903138932.28e-07
12215CLEC4G/KEL ratioGCST903141192.26e-07
12216PDLIM7/SRC ratioGCST903156392.24e-07
12217DNAJB1/METAP2 ratioGCST903145092.23e-07
12218NPTX1 levelsGCST904700782.13e-07
12219CLEC4A levelsGCST904687712.10e-07
12220Other and unspecified rosaceaFING000009512.08e-07
12221Total lipid levels in chylomicrons and extremely large VLDLGCST905010022.03e-07
12222ERBB2/FURIN ratioGCST903146862.02e-07
12223Tyrosine levelsGCST905001431.92e-07
12224SLAMF7 levelsGCST904706511.91e-07
12225ASPN levelsGCST904683771.90e-07
12226TFRC levelsGCST904516841.78e-07
12227CD19 on IgD- CD38- B cellGCST900017331.78e-07
12228CCL13 levelsGCST904685651.74e-07
12229IGF2R levelsGCST904695261.64e-07
12230CA6 levelsGCST904685151.64e-07
12231APP/HBEGF ratioGCST903133241.59e-07
12232OSMR levelsGCST904701321.58e-07
12233CD40LG levelsGCST904686321.48e-07
12234HydroceleFING000006271.44e-07
12235AmygNuclei rh volume Basal-nucleusGCST900026591.41e-07
12236PDGFB levelsGCST904701891.41e-07
12237LRP1 levelsGCST904697971.41e-07
12238IL27 levelsGCST904690601.31e-07
12239Concentration of chylomicrons and extremely large VLDL particlesGCST905010101.24e-07
12240EGF/MANF ratioGCST903146091.20e-07
12241Red cell distribution widthGCST900259881.10e-07
12242Neutrophill count | Blood countUKBB000004971.06e-07
12243ALDH1A1/RBKS ratioGCST903132471.02e-07
12244F11R/SORT1 ratioGCST903147261.01e-07
12245COMP levelsGCST904688279.95e-08
12246Heart failure and bmi 25plusFING000006039.89e-08
12247CSF1R levelsGCST904688809.60e-08
12248NID2 levelsGCST904700489.43e-08
12249MICB_MICA/TEK ratioGCST903154468.86e-08
12250Hidradenitis suppurativaFING000006218.26e-08
12251MYH9 levelsGCST904699757.71e-08
12252ACVRL1 levelsGCST904682117.58e-08
12253Omega-6 fatty acids to total fatty acids percentageGCST905025287.55e-08
12254CD244/GP1BA ratioGCST903137667.53e-08
12255Other cancerGCST904751817.49e-08
12256BACH1/DIABLO ratioGCST903134376.61e-08
12257PLXNA4 levelsGCST904702656.52e-08
12258GP1BA/SDC4 ratioGCST903149576.49e-08
12259White blood cell count (basophil)GCST0046186.47e-08
12260ULBP2 levelsGCST904710086.32e-08
12261Left-hemisphere somatomotor network to left-hemisphere somatomotor network white-matter structural connectivityGCST903026695.97e-08
12262Tyrosine levelsGCST900929935.96e-08
12263Myeloid white cell countGCST0046265.69e-08
12264VIT levelsGCST904710415.64e-08
12265GSN levelsGCST904694095.52e-08
12266Basophil percentage of white cellsGCST0046315.50e-08
12267Glutamine levelsGCST904972855.36e-08
12268HEPACAM2 levelsGCST904694454.89e-08
12269LY9 levelsGCST904698244.38e-08
12270NECTIN2 levelsGCST904700204.18e-08
12271AKR7L levelsGCST904682753.63e-08
12272TNFSF13 levelsGCST904709213.55e-08
12273IFNAR1 levelsGCST904695123.44e-08
12274LYVE1 levelsGCST904698323.22e-08
12275ADGRE5/SEMA7A ratioGCST903131833.17e-08
12276FGFR2 levelsGCST904692332.52e-08
12277Sum basophil neutrophil countsGCST0046202.47e-08
12278Neutrophil countGCST0046292.37e-08
12279Sum neutrophil eosinophil countsGCST0046131.91e-08
12280Etiocholanolone glucuronide levelsGCST901999641.86e-08
12281NADK levelsGCST904699931.80e-08
12282ESAM levelsGCST904691521.71e-08
12283SDC4/SMAD1 ratioGCST903158201.70e-08
12284Peptic ulcer (excl. esophageal) | digestiveUKBB000006391.66e-08
12285SEMA7A levelsGCST904705751.60e-08
12286Granulocyte countGCST0046141.53e-08
12287White blood cell countGCST902786471.46e-08
12288DNAJA2/HPCAL1 ratioGCST903145031.44e-08
12289SDC4/WWP2 ratioGCST903158211.43e-08
12290INHBB levelsGCST904696141.35e-08
12291MDK levelsGCST904698771.31e-08
12292DPP4/ITGB1 ratioGCST903145401.28e-08
12293CRHBP levelsGCST904688609.08e-09
12294Basophil percentage of granulocytesGCST0046347.80e-09
12295TIMD4 levelsGCST904708666.60e-09
12296NRCAM levelsGCST904700825.92e-09
12297ADGRE5/NOTCH1 ratioGCST903131815.73e-09
12298COLEC12/LTBR ratioGCST903141824.15e-09
12299F11R levelsGCST904691644.04e-09
12300CDHR2/SSC4D ratioGCST903139653.95e-09
12301LTBR/SIRPB1 ratioGCST903153393.56e-09
12302ACP6 levelsGCST904682043.29e-09
12303ADGRE5/VCAM1 ratioGCST903131843.28e-09
12304CDH5 levelsGCST904686763.13e-09
12305SDK2 levelsGCST904705622.21e-09
12306LGALS3 levelsGCST904697611.87e-09
12307X-21829 levelsGCST902005856.44e-10
12308HSPB1/QDPR ratioGCST903150895.91e-10
12309KEL levelsGCST904696733.85e-10
12310CLEC1A/CLEC7A ratioGCST903140833.21e-10
12311DSG3/NECTIN4 ratioGCST903145601.43e-10
12312CCL24 levelsGCST904685765.63e-11
12313CD163/DSC2 ratioGCST903137338.60e-12